<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[trista morrison Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/trista+morrison.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to trista morrison]]></description>
	<s:counts start="0" returned="20" found="71" />
	<language>en-us</language>
	<item>
		<title><![CDATA[NYT Unintentionally Gives the Drug Industry a Reality Check]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005458/nyt-unintentionally-gives-the-drug-industry-a-reality-check/]]></link>
		<description><![CDATA[Top-rated comments on a New York Times article about cancer prevention show just how far drugmakers -- even those fighting cancer -- have fallen in the court of public opinion. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 29 Nov 2009 21:05:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/industry.html"><![CDATA[Industry]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005484/bankers-reveal-top-biotech-ipo-contenders-new-filer-ironwood-among-them/]]></link>
		<description><![CDATA[Ironwood Pharmaceuticals filed for an initial public offering today, a move that several biotech investors had previously predicted. Here are the other names topping their likely-filer list. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 23 Nov 2009 20:56:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Genzyme Kidney Drug Failed, Too...What Could Possibly Happen Next?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005452/genzyme-kidney-drug-failed-toowhat-could-possibly-happen-next/]]></link>
		<description><![CDATA[Just when you thought it couldn't get any worse for Genzyme, a disappointing Phase II/III trial means the end for the firm's next-generation kidney drug. What could possibly happen next? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 22 Nov 2009 21:00:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/genzyme+corp..html"><![CDATA[Genzyme Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/kidney.html"><![CDATA[Kidney]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
		<category domain="tickers">GENZ</category>
	</item>
	<item>
		<title><![CDATA[The Business Conundrums of Trying to Prevent Cancer]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005391/the-business-conundrums-of-trying-to-prevent-cancer/]]></link>
		<description><![CDATA[An article in last week's New York Times said drug companies are not particularly interested in preventing cancer -- because patients aren't particularly interested in buying drugs for cancer prevention. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Nov 2009 21:21:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[BioPure Exec Sentenced to Three Years for Faking Cancer to Avoid SEC Probe]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005338/biopure-exec-sentenced-to-three-years-for-faking-cancer-to-avoid-sec-probe/]]></link>
		<description><![CDATA[Howard Richman better hope there's no such thing as karma. The former BioPure vice president was sentenced last month to three years in prison for faking cancer to avoid an SEC investigation. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 16 Nov 2009 20:00:03 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Will Plavix Competitor Cangrelor Be a Prince Rather than a Frog for The Medicines Co.?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005315/will-plavix-competitor-cangrelor-be-a-prince-rather-than-a-frog-for-the-medicines-co/]]></link>
		<description><![CDATA[The Medicines Co., which six months ago stopped two likely-to-fail Phase III trials of antiplatelet drug cangrelor, is out to prove its frog of a drug may be a prince after all. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 15 Nov 2009 21:52:20 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/medicines+co..html"><![CDATA[Medicines Co.]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDCO</category>
		<category domain="tickers">MDCO</category>
	</item>
	<item>
		<title><![CDATA[Movie Starring Harrison Ford Tells of Novazyme CEO John Crowley's Quest to Save His Children]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005287/movie-starring-harrison-ford-tells-of-novazyme-ceo-john-crowleys-quest-to-save-his-children/]]></link>
		<description><![CDATA[The drug industry is about to get a healthy dose of heartwarming goodness with the release of the movie Extraordinary Measures, about Novazyme CEO John Crowley's quest to save his kids from Pompe disease. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 12 Nov 2009 21:33:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/quest.html"><![CDATA[Quest]]></category>
		<category domain="http://resources.bnet.com/topic/movie.html"><![CDATA[Movie]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/drug+industry.html"><![CDATA[Drug Industry]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Public Outraged Wall Street Banks Received Sought-After H1N1 Vaccines]]></title>
		<link><![CDATA[http://industry.bnet.com/financial-services/10004864/public-outraged-wall-street-banks-received-sought-after-h1n1-vaccines/]]></link>
		<description><![CDATA[Wall Street banks, already hovering near an all-time low in the court of public opinion, sparked new outrage by finagling doses of the highly sought-after H1N1 swine flu vaccine for their employees. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 11 Nov 2009 21:34:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/h1n1+flu.html"><![CDATA[H1N1 Flu]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Scandal Provides Another Reason Omeros Might Not Be the Biotech IPO Bellwether]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005233/scandal-provides-another-reason-omeros-might-not-be-the-biotech-ipo-bellwether/]]></link>
		<description><![CDATA[Omeros Corp.'s recent IPO flop may be due to factors other than a lack of investor appetite for the biotech sector: the company is embroiled in a wrongful termination lawsuit with claims of defrauding the NIH and lying about taxes. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 10 Nov 2009 20:17:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/termination.html"><![CDATA[Termination]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Despite Omeros Flop, Trius and Other Biotech IPO Hopefuls Might Fare Better]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005194/despite-omeros-flop-trius-and-other-biotech-ipo-hopefuls-might-fare-better/]]></link>
		<description><![CDATA[Trius Therapeutics added its name to the initial public offering queue on Friday, apparently undeterred by the abysmal performance of Omeros Corp., the first true biotech to go public in the current IPO window. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 08 Nov 2009 20:45:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ipo.html"><![CDATA[IPO]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/financial+planning.html"><![CDATA[Financial Planning]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Has Genta's Energizer Bunny of Cancer Drugs Finally Run Out of Juice?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005135/has-gentas-energizer-bunny-of-cancer-drugs-finally-run-out-of-juice/]]></link>
		<description><![CDATA[The most surprising thing about last week's Phase III failure of beleaguered cancer drug Genasense was that Genta's stock plummeted. Seriously, who didn't see this one coming? by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 21:56:15 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Sloppy End of Year FDA Filings Have Lower Approval Odds]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005043/sloppy-end-of-year-fda-filings-have-lower-approval-odds/]]></link>
		<description><![CDATA[In the fourth quarter, the FDA receives more new drug applications -- and approves less of them -- than at any other time of year. The reason? Companies rushing to hit self-imposed year-end deadlines. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 01 Nov 2009 21:00:49 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Hepatitis C Drugs Kill the Virus...and Your Sex Drive]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005035/hepatitis-c-drugs-kill-the-virusand-your-sex-drive/]]></link>
		<description><![CDATA[As the American Association for the Study of Liver Diseases kicks off its annual confab this week, all eyes will be on efforts to revolutionize the standard of care for hepatitis C...especially now that new data show the standard has unfortunate sexual side effects. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 27 Oct 2009 21:13:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/hepatitis.html"><![CDATA[Hepatitis]]></category>
		<category domain="http://resources.bnet.com/topic/hepatitis+c.html"><![CDATA[Hepatitis C]]></category>
		<category domain="http://resources.bnet.com/topic/virus.html"><![CDATA[Virus]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Why Biogen Idec Is Likely to Flinch Before Facet Biotech in Their Game of Chicken]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005023/why-biogen-idec-is-likely-to-flinch-before-facet-biotech-in-their-game-of-chicken/]]></link>
		<description><![CDATA[Biogen Idec's attempted hostile takeover of Facet Biotech, its partner on the potential blockbuster multiple sclerosis drug daclizumab, isn't going according to plan. And the snippy back-and-forths between the two companies are starting to ring with desperation. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 26 Oct 2009 22:18:40 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/games.html"><![CDATA[Games]]></category>
		<category domain="http://resources.bnet.com/topic/personal+technology.html"><![CDATA[Personal Technology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
	<item>
		<title><![CDATA[European Regulators to Antigenics: Take Your Subset and Shove It]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004994/european-regulators-to-antigenics-take-your-subset-and-shove-it/]]></link>
		<description><![CDATA[News that a European advisory committee won't recommend approval of  Antigenics' kidney cancer vaccine Oncophage vitespen provides yet another reminder -- in case anyone didnâ€™t catch it the first few hundred times -- that regulators don't like retrospective subset data. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 25 Oct 2009 22:19:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/regulator.html"><![CDATA[Regulator]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Amgen's Denosumab Turned Down Again, but It May Not Be as Bad as It Seems]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004960/amgens-denosumab-turned-down-again-but-it-may-not-be-as-bad-as-it-seems/]]></link>
		<description><![CDATA[When it rains at Amgen, it pours. Days after the FDA rejected two of six approval applications for bone loss drug denosumab, it nixed the rest as well. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 22 Oct 2009 22:46:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[Amgen's Denosumab Delay Not a Deal-Breaker; Cancer Remains the Big Question]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004901/amgens-denosumab-delay-not-a-deal-breaker-cancer-remains-the-big-question/]]></link>
		<description><![CDATA[The FDA's complete response letter to Amgen regarding approval of denosumab for postmenopausal osteoporosis was an unpleasant surprise that could have been much worse, but the drugâ€™s biggest test is yet to come when the agency reviews its bids in cancer. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 19 Oct 2009 21:21:38 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="tickers">AMGN</category>
	</item>
	<item>
		<title><![CDATA[How NOT to Write a Biotech Press Release: Just Ask Epeius]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004877/how-not-to-write-a-biotech-press-release-just-ask-epeius/]]></link>
		<description><![CDATA[If there is one cardinal sin in biotech communications, it is hype. Telling late-night TV viewers youâ€™ve made a miracle toaster is one thing; telling desperate and dying patients youâ€™ve made a miracle cancer drug is quite another. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 18 Oct 2009 20:26:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[UPDATED: Immunomedics Ignored, HGS Adored as Annual Rheumatology Confab Kicks Off]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004845/immunomedics-ignored-hgs-adored-as-annual-rheumatology-confab-kicks-off/]]></link>
		<description><![CDATA[The American College of Rheumatology's annual confab kicks off this weekend, and one item not on the menu is detailed Phase IIb data for Immunomedics and partner UCB's lupus drug epratuzumab. Meanwhile Human Genome Sciencesâ€™ lupus drug Benlysta looks to be the belle of the ball. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 15 Oct 2009 20:55:48 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/kick.html"><![CDATA[Kick]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
	<item>
		<title><![CDATA[Depomed Unfairly Slammed for Serada Phase III Results]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004795/depomed-unfairly-slammed-for-serada-phase-iii-results/]]></link>
		<description><![CDATA[Under-the-radar drug delivery firm Depomed doesn't deserve the heat it's been taking on mixed results from two Phase III trials of hot flash drug Serada. by Trista Morrison]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 13 Oct 2009 20:42:52 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/heat.html"><![CDATA[Heat]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/trista+morrison.html"><![CDATA[Trista Morrison]]></category>
	</item>
</channel>
</rss>
